These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Calcimimetics, parathyroid hormone, and vascular calcification in chronic kidney disease. Coen G Kidney Int; 2008 Nov; 74(10):1229-31. PubMed ID: 18974757 [TBL] [Abstract][Full Text] [Related]
31. Calciphylaxis with a protracted course in a patient with end-stage renal failure. Foo CC; Wong SN Am J Clin Dermatol; 2007; 8(1):55-8. PubMed ID: 17298109 [TBL] [Abstract][Full Text] [Related]
32. Vascular ossification-calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging role of sodium thiosulfate. Hayden MR; Tyagi SC; Kolb L; Sowers JR; Khanna R Cardiovasc Diabetol; 2005 Mar; 4():4. PubMed ID: 15777477 [TBL] [Abstract][Full Text] [Related]
33. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Shroff RC; McNair R; Figg N; Skepper JN; Schurgers L; Gupta A; Hiorns M; Donald AE; Deanfield J; Rees L; Shanahan CM Circulation; 2008 Oct; 118(17):1748-57. PubMed ID: 18838561 [TBL] [Abstract][Full Text] [Related]
34. Vascular calcification in long-term haemodialysis patients in a single unit: a retrospective analysis. Goldsmith DJ; Covic A; Sambrook PA; Ackrill P Nephron; 1997; 77(1):37-43. PubMed ID: 9380236 [TBL] [Abstract][Full Text] [Related]
35. Widespread cutaneous and systemic calcification (calciphylaxis) in patients with the acquired immunodeficiency syndrome and renal disease. Cockerell CJ; Dolan ET J Am Acad Dermatol; 1992 Apr; 26(4):559-62. PubMed ID: 1597541 [TBL] [Abstract][Full Text] [Related]
36. [Experimental study of the mechanism for vascular calcification in chronic kidney disease]. Persy V Verh K Acad Geneeskd Belg; 2008; 70(4):285-303. PubMed ID: 19166100 [TBL] [Abstract][Full Text] [Related]
37. Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Hafner J; Nobbe S; Partsch H; Läuchli S; Mayer D; Amann-Vesti B; Speich R; Schmid C; Burg G; French LE Arch Dermatol; 2010 Sep; 146(9):961-8. PubMed ID: 20855694 [TBL] [Abstract][Full Text] [Related]
38. [Pathogenesis and therapy for vascular calcification in patients on chronic hemodialysis]. Nitta K Clin Calcium; 2005 Jul; 15(7):106-14. PubMed ID: 15995305 [TBL] [Abstract][Full Text] [Related]
39. Unusual specific cutaneous lesions in myelodysplastic syndromes. Aractingi S; Bachmeyer C; Miclea JM; Vérola O; Rousselot P; Dubertret L; Daniel MT J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):187-91. PubMed ID: 7622643 [TBL] [Abstract][Full Text] [Related]
40. Mechanisms and treatment of extraosseous calcification in chronic kidney disease. Ketteler M; Rothe H; Krüger T; Biggar PH; Schlieper G Nat Rev Nephrol; 2011 Jul; 7(9):509-16. PubMed ID: 21769106 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]